Sveinn Sölvason, President and CEO, comments: "Sales in Q2 2025 amounted to USD 232 million, representing 7% reported growth, of which 5% was organic. Growth was strong in the Prosthetics & Neuro ...
Sveinn Sölvason, President and CEO, comments: "Sales in Q3 2025 amounted to USD 237 million, representing 11% reported growth, of which 7% was organic. Growth picked up in the third quarter as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback